IMU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ImmunoGen Inc

Watchlist Manager

Watchlist

Price: 28.96 EUR -0.07%

Market Cap: €1.4B

I	ImmunoGen Inc XBER:IMU	US
G	Gemfields Group Ltd JSE:GML	GG
A	Abercrombie & Fitch Co DUS:AFT	US
	Datatec Ltd F:DTT0	ZA
F	Fortinet Inc F:FO8	US
B	British American Tobacco PLC JSE:BTI	UK
I	Impianti SpA MIL:MPT	IT
	Visteon Corp NASDAQ:VC	US
	FibroGen Inc NASDAQ:KYNB	US
	Delek US Holdings Inc NYSE:DK	US
G	Genus PLC OTC:GENSF	UK
	Carnival PLC LSE:CCL	UK
	Alimentation Couche-Tard Inc TSX:ATD	CA
C	Capitec Bank Holdings Ltd JSE:CPI	ZA

Profitability Summary

ImmunoGen Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

95%

Gross Margin is Increasing

75% > 99%

Negative Operating Margin

-28%

Negative 3Y Average Operating Margin

-62%

Operating Margin is Increasing

-199% > -28%

Negative Net Margin

-26%

Negative 3Y Average Net Margin

-61%

Net Margin is Increasing

-199% > -26%

Negative Free Cash Flow Margin

-69%

Negative 3Y Average Free Cash Flow Margin

-105%

Free Cash Flow Margin is Increasing

-218% > -69%

Negative ROE

-20%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-157%

ROIC is Increasing

-582% > -74%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.